Johnson & Johnson MedTech division Biosense Webster has secured European CE mark approval for its Varipulse pulsed field ...

Cardiac arrhythmia diagnosis and treatment specialist Biosense has launched CARTO 3 System Version 8, a 3D heart mapping system used in cardiac ablation procedures. This latest version introduces new ...

Global Atrial Fibrillation Devices Industry is expected to reach US$ 17.9 Bn in 2032, likely to surge at a17.2% CAGR during ...

Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities. The ...

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...

Radiofrequency Balloon Catheter Market with a projected Compound Annual Growth Rate (CAGR) of 5.5% between 2022 and 2032.

Johnson & Johnson MedTech’s Biosense Webster today announced the launch of the latest version of its Carto 3 heart mapping system.

In this interview, Dr. Fu Wei, Director of Quality Management Department at BGI Genomics talks to AZoMedical about achieving and maintaining ISO/IEC 27001 and BS 10012 certifications. Isaac ...

The emerging field of pulsed field ablation continues to pick up speed around the globe, with Medtronic collecting a ...

Irvine: Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, has ...

IRVINE, Calif., May 8, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO ™ 3 ...